Metformin Prescription Rates for Patients with Prediabetes

References

1. 1.↵
   National Diabetes Statistics Report, 2020. Centers for Disease Control and Prevention. Published 2021. Available from: https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf.
2. 2.↵
   1. Makrilakis K,
   2. Liatis S,
   3. Tsiakou A,
   4. et al

   . Comparison of health-related quality of Life (HRQOL) among patients with pre-diabetes, diabetes and normal glucose tolerance, using the 15D-HRQOL questionnaire in Greece: the DEPLAN study. BMC Endocr Disord 2018;18:32.

   OpenUrl
3. 3.↵
   1. Leal J,
   2. Becker F,
   3. Feenstra T,
   4. et al

   . Health-related quality of life for normal glycaemia, prediabetes and type 2 diabetes mellitus: cross-sectional analysis of the ADDITION-PRO study. Diabet Med 2022;39:e14825.

   OpenUrl
4. 4.↵
   1. Sattar N,
   2. Rawshani A,
   3. Franzen S,
   4. et al

   . Age at diagnosis of type 2 diabetes mellitus and associations with cardiovascular and mortality risks. Circulation 2019;139:2228–37.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Knowler WC,
   2. Fowler SE,
   3. et al

   . 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. Diabetes Prevention Program Research G 2009;374:1677–86.

   OpenUrl
6. 6.↵
   1. Yeboah J,
   2. Bertoni AG,
   3. Herrington DM,
   4. Post WS,
   5. Burke GL

   . Impaired fasting glucose and the risk of incident diabetes mellitus and cardiovascular events in an adult population: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2011;58:140–6.

   OpenUrlFREE Full Text
7. 7.↵
   1. Wu J,
   2. Ward E,
   3. Threatt T,
   4. Lu ZK

   . Metformin prescribing in low-income and insured patients with prediabetes. J Am Pharm Assoc (2003) 2017;57:483–7.

   OpenUrl
8. 8.↵
   1. Tseng E,
   2. Yeh HC,
   3. Maruthur NM

   . Metformin use in prediabetes among U.S. adults, 2005-2012. Diabetes Care 2017;40:887–93.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Moin T,
   2. Schmittdiel JA,
   3. Flory JH,
   4. et al

   . Review of metformin use for type 2 diabetes prevention. Am J Prev Med 2018;55:565–74.

   OpenUrl
10. 10.↵
    1. Nhim K,
    2. Khan T,
    3. Gruss SM,
    4. et al

    . Primary care providers' prediabetes screening, testing, and referral behaviors. Am J Prev Med 2018;55:e39–e47.

    OpenUrl
11. 11.↵
    1. Mainous AG 3rd.,
    2. Tanner RJ,
    3. Baker R

    . Prediabetes diagnosis and treatment in primary care. J Am Board Fam Med 2016;29:283–5.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Schmittdiel JA,
    2. Adams SR,
    3. Segal J,
    4. et al

    . Novel use and utility of integrated electronic health records to assess rates of prediabetes recognition and treatment: brief report from an integrated electronic health records pilot study. Diabetes Care 2014;37:565–8

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    US Preventive Services Task Force. Screening for prediabetes and type 2 diabetes: US Preventive Services Task Force recommendation statement. JAMA 2021;326:736–43.

    OpenUrlCrossRefPubMed
14. 14.↵
    American Diabetes Association. Prevention or delay of type 2 diabetes: standards of medical care in diabetes-2020. Diabetes Care 2020;43:S32–S36.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    Diabetes Prevention Program Research Group. The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention. Diabetes Care 2012;35:723–30. doi:10.2337/dc11-1468.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Moin T,
    2. Li J,
    3. Duru OK,
    4. et al

    . Metformin prescription for insured adults with prediabetes from 2010 to 2012: a retrospective cohort study. Ann Intern Med 2015;162:542–8.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Gregg EW,
    2. Moin T

    . New USPSTF recommendations for screening for prediabetes and type 2 diabetes: an opportunity to create national momentum. JAMA 2021;326:701–3.

    OpenUrl
18. 18.↵
    1. Jonas DE,
    2. Crotty K,
    3. Yun JDY,
    4. et al

    . Screening for prediabetes and type 2 diabetes: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 2021;326:744–60.

    OpenUrl